Strides Pharma Science (NSE:STAR) Operating Cash Flow per Share : ₹0.00 (TTM As of Dec. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Strides Pharma Science Operating Cash Flow per Share?

Strides Pharma Science's operating cash flow per share for the three months ended in Dec. 2024 was ₹0.00. Strides Pharma Science's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2024 was ₹0.00.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 12.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Strides Pharma Science's Operating Cash Flow per Share or its related term are showing as below:

NSE:STAR' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -51.7 Med: 3.4 Max: 51.6
Current: 12.8

During the past 13 years, Strides Pharma Science's highest 3-Year average Operating Cash Flow per Share Growth Rate was 51.60% per year. The lowest was -51.70% per year. And the median was 3.40% per year.

NSE:STAR's 3-Year OCF Growth Rate is ranked better than
55.08% of 777 companies
in the Drug Manufacturers industry
Industry Median: 8.7 vs NSE:STAR: 12.80

Strides Pharma Science Operating Cash Flow per Share Historical Data

The historical data trend for Strides Pharma Science's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Strides Pharma Science Operating Cash Flow per Share Chart

Strides Pharma Science Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Operating Cash Flow per Share

Get a 7-Day Free Trial

22.86

53.67

-28.71

4.93

76.93

Strides Pharma Science Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Operating Cash Flow per Share	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Strides Pharma Science's Operating Cash Flow per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Strides Pharma Science's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Strides Pharma Science's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Strides Pharma Science's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Strides Pharma Science's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

Strides Pharma Science Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Strides Pharma Science's Operating Cash Flow per Share for the fiscal year that ended in Mar. 2024 is calculated as

Operating Cash Flow per Share (A: Mar. 2024 )	=	Cash Flow from Operations (A: Mar. 2024 )	/	Shares Outstanding (Diluted Average) (A: Mar. 2024 )
	=	7010.65	/	91.127
	=	76.93

Strides Pharma Science's Operating Cash Flow per Share for the quarter that ended in Mar. 2024 is calculated as

Operating Cash Flow per Share (Q: Dec. 2024 )	=	Cash Flow from Operations (Q: Dec. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2024 )
	=	0	/	92.090
	=	0.00

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.00

Strides Pharma Science Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Strides Pharma Science's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Strides Pharma Science Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Strides Pharma Science Ltd (NSE:STAR) » Definitions » Operating Cash Flow per Share

Traded in Other Exchanges

532531:India

Address

Strides House, Bannerghatta Road, Bilekahalli, Bengaluru, KA, IND, 560 076

Website

https://www.strides.com

Strides Pharma Science Ltd is a specialty and generic drug manufacturer. The company focuses on developing niche and complex pharmaceutical products across therapeutic segments for regulated and emerging markets. Strides' emerging-market plan focuses on branded generics for the treatment of chronic therapies. The company considers merger and acquisition investment as a potential component of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities. The company's reportable segment are; Pharmaceutical & Bio-pharmaceutical.

Strides Pharma Science Headlines

No Headlines